Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the efficacy of proton pump inhibitor (PPI), comparing
to the mucosal defensive drug, in the prevention of the recurrence of gastric and/or duodenal
ulcers during 12 weeks observation in patients receiving low-dose aspirin for vascular
protection.
Phase:
Phase 3
Details
Lead Sponsor:
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan Translational Research Informatics Center, Kobe, Hyogo, Japan